IPS2-sci-sec dataset on hPSC derived cardiomyocytes at day 23
Ontology highlight
ABSTRACT: Proof of principle and testing experiments on iPS2-sci-seq have been performed on two batches of hPSC-derived cardiomyocytes at day 23. Cells have been treated with Tetracycline throughout differentiation. For this experiment it was used a 2-level of indexing sci-RNAseq protocol (Cao J. et. al, Science 2017). During RT and PCR indexing steps, additional primers have been used to enrich for UCI and shRNA barcodes for the iPS2-seq pipeline. Sequencing has been performed on a NextSeq 500 with a High Output kit 75 cycles. Read1, 18 cycles; Index1, 10 cycles; Index2, 10 cycles, Read2, 52 cycles.
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Homo sapiens
SUBMITTER:
PROVIDER: E-MTAB-14102 | biostudies-arrayexpress |
SECONDARY ACCESSION(S): ERP160365
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA